<DOC>
	<DOCNO>NCT01543490</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety ISV-305 ( Dexamethasone DuraSiteÂ® ) compare Vehicle treatment subject Non-Bacterial Blepharitis .</brief_summary>
	<brief_title>Comparative Study Evaluate ISV-305 Compared Vehicle Blepharitis Subjects</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<criteria>Are least 18 year age . Signature subject legally authorize representative Informed Consent Form . Are willing able follow instruction attend study visit . Are willing avoid disallow medication duration study If female childbearing potential , agree submit urine sample pregnancy test use effective contraception duration study . Additional inclusion criterion also apply . Have know sensitivity poor tolerance component study drug . Have eyelid surgery study eye within twelve ( 12 ) month prior Visit 1 study . Have acute ocular infection ( bacterial , viral fungal ) active ocular inflammation blepharitis study eye . Have use topical corticosteroid medication topical ophthalmic solution investigator feel may interfere study parameter within 14 day enrollment . Be currently pregnant , nursing , plan pregnancy ; positive urine pregnancy test . Have prior ( within 30 day begin study treatment ) anticipate concurrent use investigational drug device . Have condition situation , investigator 's opinion , may put subject increase risk , confound study data , interfere significantly subject 's study participation . Additional exclusion criterion also apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>